Anti-B7H3 antibody-exatecan analog conjugate and medicinal use thereof
US12377163B2 · kind B2 · utility
0Cited by
0References
40Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 25, 2019 |
| Grant date | Aug 5, 2025 |
| Priority date | — |
| Expiry date | Dec 2, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/77
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed by the present invention are an anti-B7H3 antibody-exatecan analog conjugate, a preparation method therefor and an anti-tumor medicinal use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.